Fairfield, Connecticut, United States The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2017. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are mHealth, Health Care. Among the most popular portfolio startups of the fund, we may highlight Figur8, Babyscripts, Cohero Health.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the P5 Health Ventures, startups are often financed by MIT delta v, BioAdvance, 1776 Ventures. The meaningful sponsors for the fund in investment in the same round are Zaffre Investments, Ysios Capital, Wavemaker Partners. In the next rounds fund is usually obtained by StartUp Health, Samsung NEXT, Omron Healthcare.
We also calculated 2 valuable employees in our database.
Related Funds
| Fund Name | Location |
| Everbright Financial Holding Asset Management | Beijing, Beijing, China |
| Far East Horizon | China, Hong Kong, Hong Kong Island |
| Gett | England, London, United Kingdom |
| Hangzhou Zhiyan Dongli Jishu Management Consulting | China, Hangzhou, Zhejiang |
| Medytox | Seoul-t'ukpyolsi, South Korea, Yeoksamdong |
| Nabo Capital | - |
| New World Health | - |
| NTT DATA Getronics Corp. | Chiyoda, Japan |
| On-Line Ventures | Florida, Jacksonville, United States |
| Oriental Patron | China, Hong Kong, Hong Kong Island |
| Orlando Healthcare Ventures | - |
| Quadrant Management | Brooklyn, New York, United States |
| RBO Ventures | California, Santa Monica, United States |
| RMKB Ventures | - |
| Saison Ventures | Chiyoda, Japan |
| Tekelec International | Morrisville, North Carolina, United States |
| Terra Funda | - |
| The Stevanato Group | Italy, Veneto, Veneto |
| Western Securities | China, Shaanxi, Xianyang |
| Xenos | Canada, Ontario, Richmond Hill |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Genialis | $13M | 29 Mar 2023 | Houston, Texas, United States | ||
Clarapath | $16M | 17 Nov 2021 | New York, New York, United States | ||
FIGUR8 | $12M | 23 Jun 2021 | Boston, Massachusetts, United States | ||
Hawthorne Effect | $20M | 09 Jun 2021 | California, United States | ||
Conversa Health | $8M | 19 Jan 2021 | Portland, Oregon, United States | ||
Conversa Health | $12M | 11 Jun 2020 | Portland, Oregon, United States | ||
FIGUR8 | $4M | 27 Aug 2019 | Boston, Massachusetts, United States | ||
Iterative Scopes | $5M | 15 Jun 2019 | Cambridge, Massachusetts, United States | ||
Babyscripts | $7M | 20 Jul 2017 | District of Columbia, United States |
– FIGUR8, the med tech startup that’s developed the most advanced wearable musculoskeletal technology on the market, announced a new round of financing.
– The company has raised $12 million in Series A financing led by Taiwania Capital with participation from new and existing investors that include the MIT-affiliated E14 Fund, Phoenix Venture Partners, and P5 Health Ventures, among others.
– Measuring musculoskeletal performance and recovery has historically been impossible without expensive imaging and has been limited to visual and hands-on assessments that provide little to no objective data.
– Hawthorne Effect, a San Francisco CA-based company which offers solutions for decentralizing clinical trials, raised $20M in Series A funding.
– The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures.
– The company intends to use the funds to accelerate growth and help scale operations.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Genialis | $13M | 29 Mar 2023 | Houston, Texas, United States | ||
Clarapath | $16M | 17 Nov 2021 | New York, New York, United States | ||
FIGUR8 | $12M | 23 Jun 2021 | Boston, Massachusetts, United States | ||
Hawthorne Effect | $20M | 09 Jun 2021 | California, United States | ||
Conversa Health | $8M | 19 Jan 2021 | Portland, Oregon, United States | ||
Conversa Health | $12M | 11 Jun 2020 | Portland, Oregon, United States | ||
FIGUR8 | $4M | 27 Aug 2019 | Boston, Massachusetts, United States | ||
Iterative Scopes | $5M | 15 Jun 2019 | Cambridge, Massachusetts, United States | ||
Babyscripts | $7M | 20 Jul 2017 | District of Columbia, United States |
